Megavog MF 0.2/500 Tablet (Metformin 500mg / Voglibose 0.2mg)
$40.00 – $101.00
Country of Origin | india |
---|---|
Dosage Form | Tablets |
Generic Name | Metformin |
Indication | Type 2 diabetes mellitus |
Packaging | 10 tablets in 1 strip |
Manufacturer | Aristo Pharmaceuticals Pvt Ltd |
Composition | Metformin (500mg) + Voglibose (0.2mg) |
Megavog MF 0.2/500 Tablet (Metformin 500mg / Voglibose 0.2mg) | |||
Pack Size | Price | Price/Unit | Add To Cart |
50 Tablet/s | $40.00 (0.8/unit) | $0.8 | |
100 Tablet/s | $73.00 (0.73/unit) | $0.73 | |
150 Tablet/s | $101.00 (0.67/unit) | $0.67 |
About Megavog MF 0.2/500 Tablet
Megavog MF 0.2/500 Tablet 10’s belongs to the class of anti-diabetic drugs. It is used in the treatment of type 2 diabetes mellitus. Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produces little or no insulin at all.
Megavog MF 0.2/500 Tablet 10’s is composed of two medicines, namely voglibose and metformin. Voglibose belongs to the class of alpha-glucosidase inhibitors. It is used in the treatment of diabetes mellitus and acts by delaying glucose absorption. Metformin belongs to the class of biguanides and is used to manage blood sugar levels, particularly in obese patients.
Voglibose acts by inhibiting the intestinal enzymes, which break complex sugars into simple sugars such as glucose. This process prevents the rise of blood glucose levels. Metformin exhibits non pancreatic effect to reduce serum glucose levels without increasing insulin secretion. It is also known as an insulin sensitizer as it increases the effects of insulin. Metformin is considered to be a unique anti-diabetic drug since it does not cause hypoglycemia (lowered blood sugar levels).
Megavog MF 0.2/500 Tablet 10’s is an orally administered drug. Take this drug with food at regular intervals as prescribed by your doctor to avoid stomach upset. Do not crush, chew or break the tablet. Your doctor will decide the dosage form, and this may change timely depending on your blood sugar levels. Do not stop taking Megavog MF 0.2/500 Tablet 10’s on your own, since it may cause a rise in your blood sugar levels leading to other health issues like kidney damage, blindness and loss of limbs. The common side effects of Megavog MF 0.2/500 Tablet 10’s include nausea, vomiting, changes in taste, diarrhea, dizziness, stomach pain, shortness of breath, skin rash, bloating, and flatulence (intestinal wind/gas). Although not everyone experiences these side effects, if they occur, seek medical attention.
Before starting Megavog MF 0.2/500 Tablet 10’s, let your doctor know if you have any medical history of anaemia (low hemoglobin levels), seizures (fits), heart, kidney, and liver diseases. Megavog MF 0.2/500 Tablet 10’s does not cause hypoglycemia (low blood sugar levels). However, when used with other diabetic drugs like insulin or sulfonylureas, it can lead to hypoglycemia. Also, speak to your doctor if you are on restricted food or fluid intake since Megavog MF 0.2/500 Tablet 10’s causes dehydration, low blood sugar, and kidney damage. Do not take Megavog MF 0.2/500 Tablet 10’s if you have gastrointestinal diseases like ulcerative colitis or Crohn’s disease. Do not take or stop Megavog MF 0.2/500 Tablet 10’s, if the doctor did not advise you to do so.
Uses of Megavog MF 0.2/500 Tablet 10’s
Type 2 Diabetes mellitus
Medicinal Benefits
Megavog MF 0.2/500 Tablet 10’s is fixed dose medication used to treat type 2 diabetes mellitus. Voglibose belongs to the class of alpha-glucosidase inhibitors. It delays glucose absorption by inhibiting the intestinal enzymes, which break complex sugars into simple sugars such as glucose. This process prevents the rise of blood glucose levels immediately after meals.
Metformin belongs to the class of biguanides. It shows the non-pancreatic effect to reduce serum glucose levels without increasing the insulin secretion. It is also known as an insulin sensitizer as it increases the effects of insulin. It is considered to be a unique anti-diabetic drug since it does not lower the blood sugar levels. Metformin does not cause weight gain in most cases.
Related Product
Directions for Use
Storage
Side Effects of Megavog MF 0.2/500 Tablet 10’s
Most of the side effects of Megavog MF 0.2/500 Tablet 10’s do not require medical attention and gradually resolve over time. Megavog MF 0.2/500 Tablet 10’s can cause common side effects like nausea, vomiting, changes in taste, diarrhea, dizziness, stomach pain, shortness of breath, skin rash, bloating, and flatulence (intestinal wind/gas). Seek medical advice if these side effects persist longer.
Some less common side effects of Megavog MF 0.2/500 Tablet 10’s include pneumatosis intestinalis (gas-filled cysts on the bowel wall) when used along with other alpha-gastrointestinal drugs and lactic acidosis (a rare, but serious metabolic complication of excess lactic acid in the blood that is caused by metformin accumulation).
The risk of lactic acidosis is high in people with kidney, liver, and heart diseases. It is essential to speak to your doctor about your medical history before you take Megavog MF 0.2/500 Tablet 10’s. If any of these side effects occur and persist longer, call your doctor for emergency treatment.
In-Depth Precautions and Warning
Drug Warnings
Megavog MF 0.2/500 Tablet 10’s may increase the risk of cardiovascular diseases and hypoglycemic conditions in renal and liver disease patients. It can cause pneumatosis intestinalis (gas-filled cysts on the bowel wall) when used along with other alpha-gastrointestinal drugs. It is advised to monitor the gastrointestinal side effects thoroughly to rule out the possibility of pneumatosis intestinalis.
Megavog MF 0.2/500 Tablet 10’s has an increased risk of lactic acidosis (a rare, but serious metabolic complication of excess lactic acid in the blood that is caused by metformin accumulation). The risk of lactic acidosis is high in older people with kidney, liver, and heart diseases. Hence, brief your medical history and take advice from your doctor before starting Megavog MF 0.2/500 Tablet 10’s. Avoid consuming excessive alcohol as it can potentiate lactic acidosis.
Drug Interactions
Drug-Drug Interaction: Megavog MF 0.2/500 Tablet 10’s may interact with anti-depressants (selegiline, isocarboxazid, phenelzine), anti-inflammatory drugs (prednisolone, phenylbutazone), drugs that treat fluid retention (metolazone, hydrochlorothiazide, chlorothiazide), medicines used to treat high blood pressure (propranolol, metoprolol), anabolic, and corticosteroids. Please check the instruction leaflet that comes with the medication before you take Megavog MF 0.2/500 Tablet 10’s.
Drug-Food Interaction: Limit alcohol intake since it affects blood sugar levels. Avoid fatty foods and include healthy carbohydrates in your diet.
Drug-Disease Interaction: Tell your doctor before taking Megavog MF 0.2/500 Tablet 10’s if you have a medical history of allergic reactions to medicines, heart diseases, liver, and kidney problems. Megavog MF 0.2/500 Tablet 10’s may cause pneumatosis intestinalis (gas-filled cysts on the bowel wall) when used along with other alpha-gastrointestinal drugs.
Be the first to review “Megavog MF 0.2/500 Tablet (Metformin 500mg / Voglibose 0.2mg)” Cancel reply
Related products
Diabetes
Diabetes
Diabetes
Diabetes
Reviews
There are no reviews yet.